Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP563116.RAd1zB3KizGpFqSl8EPv9vQtXrIaQI9CO8W6llH5D-SoQ130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP563116.RAd1zB3KizGpFqSl8EPv9vQtXrIaQI9CO8W6llH5D-SoQ130_assertion type Assertion NP563116.RAd1zB3KizGpFqSl8EPv9vQtXrIaQI9CO8W6llH5D-SoQ130_head.
- NP563116.RAd1zB3KizGpFqSl8EPv9vQtXrIaQI9CO8W6llH5D-SoQ130_assertion description "[The results showed that: (1) The genotype frequency of IL-8 -251AT and TT was significantly higher in the cervical cancer group than in the normal control group (OR=2.290 and 2.619 respectively, P=0.001), and it was also higher in the lymphatic metastasis group than that without metastasis (OR=2.917, P=0.035); (2) The frequency of MMP-7 -181G/G genotype was significantly higher in the cervical cancer group and in the lymphatic metastasis group (P<0.05); (3) The incidence of IL-8 mutation was two times higher in IIa cervical cancer group than in Ib1 and Ib2 cervical cancer group (P=0.006).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP563116.RAd1zB3KizGpFqSl8EPv9vQtXrIaQI9CO8W6llH5D-SoQ130_provenance.
- NP563116.RAd1zB3KizGpFqSl8EPv9vQtXrIaQI9CO8W6llH5D-SoQ130_assertion evidence source_evidence_literature NP563116.RAd1zB3KizGpFqSl8EPv9vQtXrIaQI9CO8W6llH5D-SoQ130_provenance.
- NP563116.RAd1zB3KizGpFqSl8EPv9vQtXrIaQI9CO8W6llH5D-SoQ130_assertion SIO_000772 21336735 NP563116.RAd1zB3KizGpFqSl8EPv9vQtXrIaQI9CO8W6llH5D-SoQ130_provenance.
- NP563116.RAd1zB3KizGpFqSl8EPv9vQtXrIaQI9CO8W6llH5D-SoQ130_assertion wasDerivedFrom befree-20150227 NP563116.RAd1zB3KizGpFqSl8EPv9vQtXrIaQI9CO8W6llH5D-SoQ130_provenance.
- NP563116.RAd1zB3KizGpFqSl8EPv9vQtXrIaQI9CO8W6llH5D-SoQ130_assertion wasGeneratedBy ECO_0000203 NP563116.RAd1zB3KizGpFqSl8EPv9vQtXrIaQI9CO8W6llH5D-SoQ130_provenance.